DXCM Q1 2026 Earnings EPS Surges Past Estimates by 17 Amidst Market Skepticism Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates HMY Q2 2016 Earnings EPS Miss by 5475 Yet Stock Rallies 716 VRSN Q1 2026 Earnings Earnings Beat Expectations Driven by Domain Base Stability CLLS Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Despite No Revenue FMC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Challenges